Day One Biopharmaceuticals Cash from Financing (TTM) Analysis

Day One Biopharmaceuticals Inc (DAWN)

16.60 -0.58 (-3.35%) USD | NASDAQ | May 06, 16:00

16.60 0.00 (0.00%) After-Hours: 19:38

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	164.00M
September 30, 2023	165.32M
June 30, 2023	167.26M
March 31, 2023	167.08M
December 31, 2022	165.90M
September 30, 2022	164.30M
June 30, 2022	161.63M

Date	Value
March 31, 2022	168.24M
December 31, 2021	297.12M
September 30, 2021	326.78M
June 30, 2021	327.39M
March 31, 2021	158.86M
December 31, 2020	29.98M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

29.98M

Minimum

Dec 2020

327.39M

Maximum

Jun 2021

189.53M

Average

165.90M

Median

Dec 2022

Cash from Financing (TTM) Benchmarks